Proactive Investors - Run By Investors For Investors

Lexaria Bioscience Corp announces beverage license deal with California cannabis company

The company said the five-year definitive agreement will provide its Dehydratech technology to a private California-based cannabis company for use in certain cannabis-based beverages
cannabis oil
Lexaria has multiple patents pending in over 40 countries and already has patents in the US and in Australia for Dehydratech

Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP), announced Wednesday that it has inked an agreement via subsidary Lexaria CanPharm ULC to provide its Dehydratech technology to a private California-based cannabis company for use in certain cannabis-based beverages, which will be produced and sold in California and Nevada. 

The Kelowna-headquartered company said in a release that financial terms of the agreement will not be disclosed and the definitive agreement is for five years. 

The Dehydratech-enabled beverages are protected under Lexaria's existing US-granted patents and may include any combination of ready-to-drink beverages such as non-alcoholic beers, wines and spirits; cold or hot coffee or teas, sports drinks and more.

READ: Lexaria Bioscience renews CEO Chris Bunka and President John Docherty's contracts

Lexaria's technology, Dehydratech, allows cannabidiol (CBD) and other oils to be dehydrated into an odorless, tasteless powder and mixed with xanthan gum, corn flour and other base ingredients which can then be added to foods, drinks and creams.

"Lexaria is currently experiencing unprecedented demand in several North American markets for use of its technology for beverage applications," noted the company in the release. 

Lexaria has multiple patents pending in over 40 countries and already has patents in the US and in Australia for Dehydratech.

Shares of Lexaria were at C$1.36 on Wednesday. 

Contact Katie Lewis at [email protected]

 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full LXX profile View Profile

Lexaria Bioscience Corp Timeline

Related Articles

cannabis
August 28 2018
Tidal Royalty provides capital to help grow licenced US cannabis firms in exchange for receiving a percentage of future top-line revenues.
cannabis bud on tray
April 25 2019
Armed with a new partnership with Canada's largest pharmacy and an international cultivator, Flowr is aiming to provide medicinal and recreational consumers around the world with premium, high-quality cannabis
medical cannabis concept
February 11 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use